Westyn Branch-Elliman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antibiotic Prophylaxis | 10 | 2020 | 628 | 4.360 |
Why?
|
Anti-Infective Agents | 8 | 2023 | 942 | 3.690 |
Why?
|
Surgical Wound Infection | 12 | 2021 | 1498 | 3.120 |
Why?
|
Pacemaker, Artificial | 5 | 2020 | 767 | 2.450 |
Why?
|
Infection Control | 7 | 2020 | 953 | 1.850 |
Why?
|
Clostridium Infections | 4 | 2019 | 507 | 1.770 |
Why?
|
Defibrillators, Implantable | 5 | 2022 | 1405 | 1.660 |
Why?
|
Anti-Bacterial Agents | 15 | 2022 | 7080 | 1.540 |
Why?
|
Prosthesis-Related Infections | 4 | 2020 | 509 | 1.510 |
Why?
|
Acute Kidney Injury | 5 | 2021 | 1863 | 1.500 |
Why?
|
Vancomycin | 6 | 2020 | 507 | 1.480 |
Why?
|
Staphylococcal Infections | 7 | 2020 | 1371 | 1.420 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 6 | 2020 | 666 | 1.230 |
Why?
|
Ambulatory Surgical Procedures | 4 | 2019 | 451 | 1.210 |
Why?
|
Informed Consent | 2 | 2021 | 963 | 1.040 |
Why?
|
Catheter-Related Infections | 2 | 2017 | 240 | 0.990 |
Why?
|
Virus Diseases | 2 | 2022 | 698 | 0.930 |
Why?
|
Cross Infection | 5 | 2020 | 1405 | 0.930 |
Why?
|
Mastitis | 2 | 2013 | 42 | 0.920 |
Why?
|
Urinary Tract Infections | 2 | 2020 | 779 | 0.870 |
Why?
|
Electronic Health Records | 6 | 2021 | 4275 | 0.870 |
Why?
|
Therapeutic Human Experimentation | 1 | 2021 | 42 | 0.850 |
Why?
|
Veterans Health | 3 | 2023 | 199 | 0.830 |
Why?
|
Pyuria | 1 | 2020 | 34 | 0.800 |
Why?
|
Pneumonia, Ventilator-Associated | 2 | 2015 | 261 | 0.800 |
Why?
|
Hospitals, Veterans | 8 | 2022 | 404 | 0.770 |
Why?
|
Norovirus | 1 | 2020 | 31 | 0.760 |
Why?
|
Quarantine | 1 | 2022 | 169 | 0.750 |
Why?
|
Civil Defense | 1 | 2021 | 110 | 0.720 |
Why?
|
Patient Identification Systems | 1 | 2019 | 79 | 0.710 |
Why?
|
Abscess | 2 | 2013 | 596 | 0.700 |
Why?
|
Antiviral Agents | 3 | 2022 | 2807 | 0.700 |
Why?
|
Guideline Adherence | 3 | 2019 | 2326 | 0.690 |
Why?
|
Bacterial Infections | 2 | 2017 | 1425 | 0.680 |
Why?
|
Catheters, Indwelling | 2 | 2017 | 419 | 0.660 |
Why?
|
Algorithms | 7 | 2021 | 13765 | 0.650 |
Why?
|
Gastroenteritis | 1 | 2020 | 258 | 0.650 |
Why?
|
Veterans | 5 | 2022 | 2241 | 0.630 |
Why?
|
Population Surveillance | 2 | 2020 | 2652 | 0.610 |
Why?
|
Sterilization | 1 | 2017 | 131 | 0.590 |
Why?
|
Outpatients | 3 | 2023 | 1370 | 0.570 |
Why?
|
Documentation | 2 | 2020 | 870 | 0.570 |
Why?
|
beta-Lactams | 1 | 2017 | 153 | 0.570 |
Why?
|
Laboratories, Hospital | 1 | 2017 | 196 | 0.540 |
Why?
|
Staphylococcus aureus | 3 | 2019 | 1401 | 0.540 |
Why?
|
Data Mining | 1 | 2020 | 551 | 0.540 |
Why?
|
Neutropenia | 1 | 2019 | 877 | 0.530 |
Why?
|
Intensive Care Units | 4 | 2018 | 3449 | 0.520 |
Why?
|
United States Department of Veterans Affairs | 5 | 2020 | 858 | 0.520 |
Why?
|
Bacteremia | 1 | 2021 | 968 | 0.520 |
Why?
|
Housekeeping, Hospital | 1 | 2014 | 16 | 0.510 |
Why?
|
Immunocompromised Host | 1 | 2019 | 867 | 0.510 |
Why?
|
Ligation | 1 | 2015 | 480 | 0.510 |
Why?
|
Disease Outbreaks | 4 | 2021 | 1742 | 0.500 |
Why?
|
Environmental Microbiology | 1 | 2014 | 48 | 0.500 |
Why?
|
Patients' Rooms | 1 | 2014 | 62 | 0.500 |
Why?
|
Communicable Diseases | 2 | 2021 | 800 | 0.490 |
Why?
|
Pandemics | 4 | 2023 | 7306 | 0.490 |
Why?
|
Education, Professional | 1 | 2014 | 51 | 0.490 |
Why?
|
Office Visits | 1 | 2018 | 627 | 0.490 |
Why?
|
Computer Systems | 1 | 2015 | 479 | 0.480 |
Why?
|
Data Collection | 2 | 2020 | 3319 | 0.480 |
Why?
|
Cost-Benefit Analysis | 2 | 2017 | 5269 | 0.480 |
Why?
|
Retrospective Studies | 26 | 2023 | 72439 | 0.470 |
Why?
|
Esophageal and Gastric Varices | 1 | 2015 | 199 | 0.470 |
Why?
|
Influenza Vaccines | 1 | 2019 | 686 | 0.460 |
Why?
|
Humans | 70 | 2023 | 715636 | 0.450 |
Why?
|
Hypersensitivity | 1 | 2020 | 1034 | 0.450 |
Why?
|
Hospital Costs | 2 | 2017 | 978 | 0.440 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2015 | 259 | 0.430 |
Why?
|
Luminescent Measurements | 1 | 2014 | 376 | 0.430 |
Why?
|
Disinfection | 1 | 2014 | 200 | 0.430 |
Why?
|
Anti-Inflammatory Agents | 1 | 2022 | 1787 | 0.430 |
Why?
|
Hysterectomy | 1 | 2018 | 902 | 0.430 |
Why?
|
Drug Contamination | 1 | 2012 | 152 | 0.410 |
Why?
|
Patient Admission | 1 | 2018 | 1396 | 0.390 |
Why?
|
Postpartum Period | 2 | 2013 | 985 | 0.380 |
Why?
|
Program Development | 1 | 2017 | 1333 | 0.380 |
Why?
|
Disease Transmission, Infectious | 1 | 2015 | 543 | 0.370 |
Why?
|
Nursing Staff, Hospital | 1 | 2013 | 336 | 0.370 |
Why?
|
Surgical Procedures, Operative | 2 | 2019 | 1875 | 0.350 |
Why?
|
Schools | 3 | 2022 | 1379 | 0.350 |
Why?
|
Influenza, Human | 1 | 2019 | 1386 | 0.340 |
Why?
|
United States | 19 | 2022 | 67894 | 0.340 |
Why?
|
Secondary Prevention | 1 | 2015 | 1511 | 0.340 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 1984 | 0.330 |
Why?
|
Aged | 23 | 2022 | 162383 | 0.330 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2015 | 1073 | 0.320 |
Why?
|
Natural Language Processing | 1 | 2015 | 953 | 0.320 |
Why?
|
Respiration, Artificial | 2 | 2022 | 2466 | 0.320 |
Why?
|
Adenosine Triphosphate | 1 | 2014 | 2023 | 0.310 |
Why?
|
Respiratory Tract Infections | 1 | 2015 | 977 | 0.310 |
Why?
|
Workload | 1 | 2013 | 856 | 0.300 |
Why?
|
Cohort Studies | 10 | 2022 | 40042 | 0.300 |
Why?
|
Vaccination | 4 | 2022 | 2936 | 0.270 |
Why?
|
Biomedical Research | 1 | 2021 | 3265 | 0.270 |
Why?
|
Endoscopy | 1 | 2015 | 1756 | 0.270 |
Why?
|
Research Design | 1 | 2021 | 5913 | 0.260 |
Why?
|
Drug Resistance, Multiple, Bacterial | 2 | 2021 | 592 | 0.260 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2019 | 3291 | 0.260 |
Why?
|
Quality Improvement | 5 | 2020 | 3738 | 0.240 |
Why?
|
Middle Aged | 21 | 2022 | 214618 | 0.240 |
Why?
|
Sisomicin | 1 | 2021 | 7 | 0.220 |
Why?
|
Aged, 80 and over | 11 | 2022 | 58288 | 0.220 |
Why?
|
Hepatitis C | 1 | 2012 | 1521 | 0.220 |
Why?
|
Male | 25 | 2022 | 350156 | 0.220 |
Why?
|
Klebsiella | 1 | 2021 | 51 | 0.220 |
Why?
|
Female | 25 | 2022 | 377052 | 0.200 |
Why?
|
Mass Vaccination | 1 | 2022 | 108 | 0.200 |
Why?
|
Incidence | 4 | 2022 | 20761 | 0.200 |
Why?
|
Caliciviridae Infections | 1 | 2020 | 26 | 0.190 |
Why?
|
Risk Factors | 10 | 2022 | 70927 | 0.190 |
Why?
|
Paraproteinemias | 1 | 2022 | 247 | 0.190 |
Why?
|
Academic Medical Centers | 3 | 2020 | 2788 | 0.190 |
Why?
|
Oseltamivir | 1 | 2019 | 71 | 0.180 |
Why?
|
Cefazolin | 1 | 2019 | 97 | 0.180 |
Why?
|
Inappropriate Prescribing | 1 | 2022 | 211 | 0.180 |
Why?
|
Radiology, Interventional | 1 | 2023 | 424 | 0.180 |
Why?
|
Renal Replacement Therapy | 1 | 2021 | 253 | 0.180 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 634 | 0.180 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7495 | 0.170 |
Why?
|
Bacteriuria | 1 | 2019 | 98 | 0.170 |
Why?
|
Death | 1 | 2023 | 581 | 0.170 |
Why?
|
Soaps | 1 | 2018 | 24 | 0.170 |
Why?
|
Hospitalization | 3 | 2022 | 9743 | 0.170 |
Why?
|
Feedback | 1 | 2022 | 755 | 0.170 |
Why?
|
Urinalysis | 1 | 2020 | 364 | 0.170 |
Why?
|
Daptomycin | 1 | 2018 | 78 | 0.160 |
Why?
|
Goals | 1 | 2023 | 651 | 0.160 |
Why?
|
Dexamethasone | 2 | 2022 | 1925 | 0.160 |
Why?
|
Validation Studies as Topic | 1 | 2017 | 169 | 0.160 |
Why?
|
RNA, Viral | 2 | 2022 | 2869 | 0.160 |
Why?
|
Arthroplasty | 1 | 2019 | 287 | 0.160 |
Why?
|
Boston | 4 | 2020 | 9374 | 0.150 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2019 | 343 | 0.150 |
Why?
|
Treatment Outcome | 6 | 2023 | 62037 | 0.150 |
Why?
|
Electrophysiology | 1 | 2019 | 1316 | 0.150 |
Why?
|
Critical Pathways | 1 | 2020 | 456 | 0.150 |
Why?
|
Candida | 1 | 2017 | 173 | 0.140 |
Why?
|
Microbiological Techniques | 1 | 2017 | 101 | 0.140 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 14438 | 0.140 |
Why?
|
Equipment Contamination | 1 | 2017 | 177 | 0.140 |
Why?
|
Pseudomonas Infections | 1 | 2019 | 614 | 0.140 |
Why?
|
Probability | 1 | 2020 | 2493 | 0.130 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 742 | 0.130 |
Why?
|
Candidiasis | 1 | 2017 | 360 | 0.130 |
Why?
|
Surgical Instruments | 1 | 2017 | 415 | 0.130 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2017 | 470 | 0.130 |
Why?
|
Health Personnel | 2 | 2019 | 3045 | 0.120 |
Why?
|
Communicable Diseases, Emerging | 1 | 2015 | 150 | 0.120 |
Why?
|
Oxygen | 2 | 2022 | 4165 | 0.120 |
Why?
|
Decision Trees | 1 | 2015 | 523 | 0.120 |
Why?
|
Carrier State | 1 | 2017 | 536 | 0.120 |
Why?
|
Motivation | 1 | 2023 | 1897 | 0.120 |
Why?
|
Postoperative Period | 1 | 2018 | 1844 | 0.120 |
Why?
|
Sentinel Surveillance | 1 | 2014 | 301 | 0.110 |
Why?
|
Diarrhea | 1 | 2019 | 1370 | 0.110 |
Why?
|
Drug Combinations | 1 | 2017 | 1929 | 0.110 |
Why?
|
Students | 1 | 2021 | 1557 | 0.110 |
Why?
|
Markov Chains | 1 | 2015 | 991 | 0.110 |
Why?
|
Drug Utilization | 1 | 2018 | 1237 | 0.100 |
Why?
|
Diagnostic Tests, Routine | 1 | 2017 | 790 | 0.100 |
Why?
|
Case-Control Studies | 3 | 2014 | 21802 | 0.100 |
Why?
|
Device Removal | 1 | 2016 | 650 | 0.100 |
Why?
|
Adult | 11 | 2022 | 212228 | 0.100 |
Why?
|
Models, Economic | 1 | 2015 | 719 | 0.100 |
Why?
|
Quality Control | 1 | 2014 | 868 | 0.100 |
Why?
|
Triage | 1 | 2017 | 934 | 0.100 |
Why?
|
Orthopedic Procedures | 1 | 2021 | 1276 | 0.100 |
Why?
|
Operating Rooms | 1 | 2017 | 806 | 0.100 |
Why?
|
New York City | 1 | 2012 | 665 | 0.100 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12490 | 0.100 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1686 | 0.090 |
Why?
|
Aspirin | 1 | 2021 | 3187 | 0.090 |
Why?
|
Clinical Protocols | 1 | 2015 | 1474 | 0.090 |
Why?
|
Occupational Health | 1 | 2015 | 831 | 0.090 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 3014 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2019 | 1627 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2014 | 2995 | 0.080 |
Why?
|
Health Services | 1 | 2013 | 744 | 0.080 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2748 | 0.080 |
Why?
|
Intubation, Intratracheal | 1 | 2015 | 1325 | 0.080 |
Why?
|
Logistic Models | 2 | 2019 | 13606 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2017 | 2260 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3683 | 0.070 |
Why?
|
Program Evaluation | 1 | 2015 | 2538 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2022 | 13205 | 0.070 |
Why?
|
Ambulatory Care Facilities | 1 | 2012 | 884 | 0.070 |
Why?
|
Time Factors | 3 | 2018 | 40892 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2013 | 2502 | 0.070 |
Why?
|
Delivery of Health Care | 1 | 2022 | 4884 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6726 | 0.060 |
Why?
|
Preoperative Period | 2 | 2019 | 554 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 7901 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12495 | 0.060 |
Why?
|
Cost of Illness | 1 | 2013 | 1842 | 0.060 |
Why?
|
Recurrence | 1 | 2015 | 8238 | 0.060 |
Why?
|
Postoperative Complications | 2 | 2018 | 15101 | 0.060 |
Why?
|
Breast | 1 | 2011 | 1817 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3407 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8886 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5112 | 0.060 |
Why?
|
Pilot Projects | 1 | 2015 | 8078 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 11719 | 0.050 |
Why?
|
Length of Stay | 1 | 2015 | 6272 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15184 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2014 | 14887 | 0.050 |
Why?
|
Loneliness | 1 | 2022 | 143 | 0.050 |
Why?
|
Mass Screening | 2 | 2019 | 5218 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7445 | 0.050 |
Why?
|
Pregnancy | 2 | 2013 | 27366 | 0.050 |
Why?
|
Odds Ratio | 1 | 2014 | 9977 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2015 | 4054 | 0.050 |
Why?
|
Prospective Studies | 2 | 2022 | 51355 | 0.050 |
Why?
|
Young Adult | 4 | 2021 | 56137 | 0.050 |
Why?
|
Health Care Costs | 1 | 2013 | 3165 | 0.050 |
Why?
|
Plasma Cells | 1 | 2022 | 600 | 0.040 |
Why?
|
Methicillin Resistance | 1 | 2019 | 203 | 0.040 |
Why?
|
Infusions, Parenteral | 1 | 2018 | 428 | 0.040 |
Why?
|
Clinical Competence | 1 | 2013 | 4629 | 0.040 |
Why?
|
Adolescent | 3 | 2021 | 85064 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 23383 | 0.040 |
Why?
|
Hospitals | 2 | 2019 | 3373 | 0.030 |
Why?
|
Hepacivirus | 1 | 2002 | 1323 | 0.030 |
Why?
|
Geriatrics | 1 | 2018 | 377 | 0.030 |
Why?
|
Teaching | 1 | 2021 | 1182 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 20514 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2011 | 24779 | 0.030 |
Why?
|
Inpatients | 1 | 2023 | 2254 | 0.030 |
Why?
|
Educational Measurement | 1 | 2018 | 1280 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9812 | 0.020 |
Why?
|
Nose | 1 | 2012 | 494 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2019 | 1460 | 0.020 |
Why?
|
Anxiety | 1 | 2022 | 3908 | 0.020 |
Why?
|
Software | 1 | 2002 | 4393 | 0.020 |
Why?
|
Palliative Care | 1 | 2022 | 3287 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2022 | 4163 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 14878 | 0.020 |
Why?
|
Curriculum | 1 | 2018 | 3403 | 0.020 |
Why?
|
Depression | 1 | 2022 | 7261 | 0.010 |
Why?
|
Reading Frames | 1 | 2002 | 16 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6276 | 0.010 |
Why?
|
Viral Core Proteins | 1 | 2002 | 168 | 0.010 |
Why?
|
Consensus Sequence | 1 | 2002 | 381 | 0.010 |
Why?
|
Prognosis | 1 | 2022 | 28987 | 0.010 |
Why?
|
Viral Nonstructural Proteins | 1 | 2002 | 241 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2002 | 966 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 41184 | 0.010 |
Why?
|
Genome, Viral | 1 | 2002 | 678 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2002 | 2289 | 0.010 |
Why?
|
Mutation | 1 | 2002 | 29270 | 0.010 |
Why?
|
Point Mutation | 1 | 2002 | 1648 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2002 | 3964 | 0.010 |
Why?
|
Child | 1 | 2021 | 74418 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2002 | 14171 | 0.010 |
Why?
|
Computational Biology | 1 | 2002 | 3569 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 18601 | 0.010 |
Why?
|
Genotype | 1 | 2002 | 12931 | 0.000 |
Why?
|